ReviewStem cell reviews and reports2011

Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Rita Anzalone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.